Get the Stockscreener App
3.49
0.00%
0.00
Compass Therapeutics Inc stock is traded at $3.49, with a volume of 702.50K.
It is up +0.00% in the last 24 hours and up +10.09% over the past month.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
See More
Previous Close:
$3.49
Open:
$3.49
24h Volume:
702.50K
Relative Volume:
0.70
Market Cap:
$482.61M
Revenue:
-
Net Income/Loss:
$-45.44M
P/E Ratio:
-9.9714
EPS:
-0.35
Net Cash Flow:
$-42.28M
1W Performance:
+15.56%
1M Performance:
+10.09%
6M Performance:
+19.52%
1Y Performance:
+156.62%
1-Day Range:
$3.285
$3.50
1-Week Range:
$2.96
$3.615
52-Week Range:
$1.27
$4.08
Compass Therapeutics Inc Stock (CMPX) Company Profile
Name
Compass Therapeutics Inc
Sector
Industry
Phone
617-500-8099
Address
80 GUEST STREET, BOSTON
Compare CMPX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CMPX
Compass Therapeutics Inc
|
3.49 | 482.61M | 0 | -45.44M | -42.28M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-25 | Resumed | Raymond James | Outperform |
| Apr-02-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-24-25 | Initiated | Guggenheim | Buy |
| Feb-19-25 | Initiated | Piper Sandler | Overweight |
| Dec-23-24 | Initiated | D. Boral Capital | Buy |
| Nov-15-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Sep-16-24 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Jan-31-23 | Initiated | Jefferies | Buy |
| Jan-27-23 | Initiated | Stifel | Buy |
| May-23-22 | Resumed | H.C. Wainwright | Buy |
| Mar-15-22 | Initiated | Ladenburg Thalmann | Buy |
| Jan-19-22 | Initiated | B. Riley Securities | Buy |
| Dec-22-21 | Initiated | Raymond James | Outperform |
| Dec-20-21 | Initiated | SVB Leerink | Outperform |
| Dec-15-21 | Initiated | Wedbush | Outperform |
View All
Compass Therapeutics Inc Stock (CMPX) Latest News
Using Bollinger Bands to evaluate Compass Therapeutics IncSwing Trade & Stock Market Timing Techniques - Newser
Trend analysis for Compass Therapeutics Inc. this weekQuarterly Growth Report & Long-Term Capital Growth Ideas - Newser
Will Compass Therapeutics Inc. stock go up soonJuly 2025 Fed Impact & Advanced Technical Signal Analysis - Newser
Will Compass Therapeutics Inc. benefit from macro trendsJuly 2025 Trade Ideas & AI Powered Market Entry Ideas - Newser
Advanced analytics toolkit walkthrough for Compass Therapeutics Inc.Weekly Stock Report & Daily Oversold Bounce Ideas - Newser
Statistical indicators supporting Compass Therapeutics Inc.’s strengthRecession Risk & Consistent Growth Stock Picks - Newser
Technical analysis overview for Compass Therapeutics Inc. stockEarnings Growth Summary & Short-Term High Return Strategies - Newser
Will earnings trigger a reversal in Compass Therapeutics Inc.Global Markets & Detailed Earnings Play Alerts - Newser
How to escape a deep drawdown in Compass Therapeutics Inc.2025 Analyst Calls & Daily Profit Maximizing Trade Tips - Newser
Visualizing Compass Therapeutics Inc. stock with heatmapsJuly 2025 PostEarnings & Safe Entry Zone Tips - Newser
Using Bollinger Bands to evaluate Compass Therapeutics Inc.2025 Earnings Impact & Accurate Intraday Trading Signals - Newser
What MACD signals say about Compass Therapeutics Inc.Portfolio Profit Report & Growth Oriented Trade Recommendations - Newser
Is Compass Therapeutics Inc. stock bottoming outTrade Analysis Report & Risk Managed Trade Strategies - Newser
What MACD and RSI say about Compass Therapeutics Inc.2025 Macro Impact & AI Driven Stock Movement Reports - Newser
Custom strategy builders for tracking Compass Therapeutics Inc.Analyst Upgrade & Stock Market Timing Techniques - Newser
Will earnings trigger a reversal in Compass Therapeutics IncJobs Report & Free Fast Entry Momentum Trade Alerts - Newser
Applying sector rotation models to Compass Therapeutics Inc.2025 EndofYear Setup & Fast Entry High Yield Tips - Newser
Can Compass Therapeutics Inc. hit a new high this monthShort Setup & Weekly Chart Analysis and Guides - Newser
Short interest data insights for Compass Therapeutics Inc.Market Risk Summary & Daily Profit Focused Stock Screening - Newser
Technical signs of recovery in Compass Therapeutics Inc.Portfolio Risk Summary & Risk Adjusted Swing Trade Ideas - Newser
Compass Therapeutics Inc. stock retracement – recovery analysisGlobal Markets & High Return Stock Watch Alerts - Newser
What does recent volatility data suggest for Compass Therapeutics Inc.July 2025 Price Swings & Expert Verified Movement Alerts - Newser
What makes Compass Therapeutics Inc. stock price move sharplyEarnings Beat & Reliable Trade Execution Plans - Newser
Smart tools for monitoring Compass Therapeutics Inc.’s price actionQuarterly Trade Report & Daily Market Momentum Tracking - Newser
Compass Therapeutics Inc Stock (CMPX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):